MX9700511A - Inhibidores de spla2 de indolizina. - Google Patents
Inhibidores de spla2 de indolizina.Info
- Publication number
- MX9700511A MX9700511A MX9700511A MX9700511A MX9700511A MX 9700511 A MX9700511 A MX 9700511A MX 9700511 A MX9700511 A MX 9700511A MX 9700511 A MX9700511 A MX 9700511A MX 9700511 A MX9700511 A MX 9700511A
- Authority
- MX
- Mexico
- Prior art keywords
- indolizine
- compounds
- glyoxylamides
- acetamides
- spla2 inhibitors
- Prior art date
Links
- 102000005473 Secretory Phospholipases A2 Human genes 0.000 title abstract 2
- 108010031873 Secretory Phospholipases A2 Proteins 0.000 title abstract 2
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- UKVDMENMUORDKW-UHFFFAOYSA-N 2-indolizin-1-yl-2-oxoacetamide Chemical class C1=CC=CC2=C(C(=O)C(=O)N)C=CN21 UKVDMENMUORDKW-UHFFFAOYSA-N 0.000 abstract 1
- LRSNLLOKLZWSTC-UHFFFAOYSA-N 2-indolizin-1-ylacetamide Chemical class C1=CC=CC2=C(CC(=O)N)C=CN21 LRSNLLOKLZWSTC-UHFFFAOYSA-N 0.000 abstract 1
- REHUXAUXLDYKHW-UHFFFAOYSA-N 2-indolizin-1-ylacetohydrazide Chemical class C1=CC=CC2=C(CC(=O)NN)C=CN21 REHUXAUXLDYKHW-UHFFFAOYSA-N 0.000 abstract 1
- UPLAOAOFNIHFQH-UHFFFAOYSA-N 2-indolizin-3-yl-2-oxoacetamide Chemical class C1=CC=CN2C(C(=O)C(=O)N)=CC=C21 UPLAOAOFNIHFQH-UHFFFAOYSA-N 0.000 abstract 1
- LRBVPNDTTFHDIX-UHFFFAOYSA-N 2-indolizin-3-ylacetamide Chemical class C1=CC=CN2C(CC(=O)N)=CC=C21 LRBVPNDTTFHDIX-UHFFFAOYSA-N 0.000 abstract 1
- MPWVHKXRHZZZDM-UHFFFAOYSA-N 2-indolizin-3-ylacetic acid Chemical compound C1=CC=CN2C(CC(=O)O)=CC=C21 MPWVHKXRHZZZDM-UHFFFAOYSA-N 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000002478 indolizines Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compounds Of Unknown Constitution (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describe una clase de nuevos compuestos indolizina-1-funcionales e indolizina -3-funcionales junto con el uso de estos compuestos de indolizina para inhibir la liberacion de ácidos grasos mediada por sPLA2 para el tratamiento de condiciones tal como el choque séptico. Los compuestos son indolizina-1-acetamidas, hidrazidas de ácido indolizina -1-acético, indolizina 1-1-glioxilamidas, indolizina -3-acetamidas, hidrazidas de ácido indolizina -3-acético de indolizina -3-glicoxilamidas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27844594A | 1994-07-21 | 1994-07-21 | |
| PCT/US1995/009381 WO1996003383A1 (en) | 1994-07-21 | 1995-07-20 | INDOLIZINE sPLA2 INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9700511A true MX9700511A (es) | 1997-04-30 |
Family
ID=23065002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9700511A MX9700511A (es) | 1994-07-21 | 1995-07-20 | Inhibidores de spla2 de indolizina. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6645976B1 (es) |
| EP (1) | EP0772596B1 (es) |
| JP (1) | JPH10505584A (es) |
| KR (1) | KR970704695A (es) |
| CN (1) | CN1158121A (es) |
| AT (1) | ATE251158T1 (es) |
| AU (1) | AU3145995A (es) |
| BR (1) | BR9508298A (es) |
| CA (1) | CA2195570A1 (es) |
| DE (1) | DE69531864T2 (es) |
| ES (1) | ES2208685T3 (es) |
| HU (1) | HUT77867A (es) |
| MX (1) | MX9700511A (es) |
| WO (1) | WO1996003383A1 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177440B1 (en) | 1996-10-30 | 2001-01-23 | Eli Lilly And Company | Substituted tricyclics |
| US6713645B1 (en) * | 1996-10-30 | 2004-03-30 | Eli Lilly And Company | Substituted tricyclics |
| WO1998047507A1 (en) | 1997-04-24 | 1998-10-29 | Shionogi & Co., Ltd. | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
| JP2001513555A (ja) * | 1997-08-28 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | 非リウマチ様関節炎の処置方法 |
| WO1999024033A1 (en) * | 1997-11-12 | 1999-05-20 | Shionogi & Co., Ltd. | Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| AU3054399A (en) | 1998-03-31 | 1999-10-25 | Shionogi & Co., Ltd. | Pyrrolo(1,2-a)pyrazine sPLA2 inhibitor |
| IL129484A0 (en) * | 1998-04-17 | 2000-02-29 | Lilly Co Eli | Substituted tricyclics |
| CN1302300A (zh) | 1998-05-21 | 2001-07-04 | 盐野义制药株式会社 | 吡咯并[1,2－b]哒嗪sPLA2抑制剂 |
| CA2346334A1 (en) | 1998-10-14 | 2000-04-20 | Shionogi & Co., Ltd. | Composition for treating or preventing ischemia reperfusion injury |
| JP4636521B2 (ja) * | 1999-07-19 | 2011-02-23 | 塩野義製薬株式会社 | ｓＰＬＡ２阻害作用を有する三環系化合物 |
| JP4636522B2 (ja) * | 1999-08-02 | 2011-02-23 | 塩野義製薬株式会社 | ｓＰＬＡ２阻害作用を有する三環式化合物 |
| US6787545B1 (en) | 1999-08-23 | 2004-09-07 | Shiongi & Co., Ltd. | Pyrrolotriazine derivatives having spla2-inhibitory activities |
| AU7559600A (en) * | 1999-10-15 | 2001-04-23 | Shionogi & Co., Ltd. | V type and/or x type spla2 inhibitors |
| US6756376B1 (en) | 1999-11-15 | 2004-06-29 | Shionogi & Co., Ltd. | Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities |
| AU2001267823A1 (en) | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Compounds exhibiting x-type spla2 inhibiting effect |
| AU2001267825A1 (en) | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Remedies for cirrhosis |
| TWI314457B (es) | 2001-03-19 | 2009-09-11 | Shionogi & Co | |
| US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
| AU2003267071A1 (en) * | 2002-09-13 | 2004-04-30 | Synta Pharmaceuticals Corp. | Synthesis of indolizines |
| WO2005079805A1 (en) * | 2004-02-20 | 2005-09-01 | Astrazeneca Ab | Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
| JP5172661B2 (ja) * | 2005-05-18 | 2013-03-27 | エフ２ジー リミテッド | 抗真菌剤 |
| GB0518783D0 (en) * | 2005-09-14 | 2005-10-26 | Argenta Discovery Ltd | Indolizine compounds |
| GB0623209D0 (en) * | 2006-11-21 | 2007-01-03 | F2G Ltd | Antifungal agents |
| AU2009239778B2 (en) | 2008-04-24 | 2014-03-13 | F2G Ltd | Pyrrole antifungal agents |
| GB0809773D0 (en) * | 2008-05-29 | 2008-07-09 | F2G Ltd | Antifungal combination therapy |
| US20150025105A1 (en) * | 2012-02-09 | 2015-01-22 | Praveen Rao Perampalli Nekkar | Indolizine derivatives |
| DK3221308T3 (en) | 2014-11-21 | 2018-12-10 | F2G Ltd | Antifungals |
| GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
| CN111440165B (zh) * | 2020-04-13 | 2023-06-16 | 深圳职业技术学院 | 取代吲嗪类衍生物及其制备方法 |
| CN111393437B (zh) * | 2020-04-13 | 2022-11-22 | 深圳职业技术学院 | 三取代吲嗪类化合物及其制备方法 |
| TW202412770A (zh) * | 2022-05-25 | 2024-04-01 | 天主教魯汶大學 | 用於治療ｔｒｐｍ３介導之病症的吲口巾衍生物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1174124A (en) * | 1967-06-30 | 1969-12-10 | Beecham Group Ltd | Pharmacologically Active Indolizine Compounds |
| US3717644A (en) * | 1970-06-01 | 1973-02-20 | L Walter | 1-(di-lower alkyl amino lower alkyl)-2-phenyl-5,6,7,8-tetrahydroindolizines |
-
1995
- 1995-07-20 JP JP8505935A patent/JPH10505584A/ja not_active Ceased
- 1995-07-20 CA CA002195570A patent/CA2195570A1/en not_active Abandoned
- 1995-07-20 AU AU31459/95A patent/AU3145995A/en not_active Abandoned
- 1995-07-20 WO PCT/US1995/009381 patent/WO1996003383A1/en not_active Ceased
- 1995-07-20 MX MX9700511A patent/MX9700511A/es unknown
- 1995-07-20 ES ES95927422T patent/ES2208685T3/es not_active Expired - Lifetime
- 1995-07-20 DE DE69531864T patent/DE69531864T2/de not_active Expired - Fee Related
- 1995-07-20 EP EP95927422A patent/EP0772596B1/en not_active Expired - Lifetime
- 1995-07-20 BR BR9508298A patent/BR9508298A/pt not_active IP Right Cessation
- 1995-07-20 US US08/765,566 patent/US6645976B1/en not_active Expired - Fee Related
- 1995-07-20 AT AT95927422T patent/ATE251158T1/de not_active IP Right Cessation
- 1995-07-20 HU HU9700179A patent/HUT77867A/hu unknown
- 1995-07-20 CN CN95195129A patent/CN1158121A/zh active Pending
-
1997
- 1997-01-20 KR KR1019970700373A patent/KR970704695A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR970704695A (ko) | 1997-09-06 |
| EP0772596A4 (en) | 1999-01-13 |
| CN1158121A (zh) | 1997-08-27 |
| CA2195570A1 (en) | 1996-02-08 |
| HUT77867A (hu) | 1998-09-28 |
| BR9508298A (pt) | 1998-11-03 |
| US6645976B1 (en) | 2003-11-11 |
| EP0772596A1 (en) | 1997-05-14 |
| HU9700179D0 (en) | 1997-03-28 |
| AU3145995A (en) | 1996-02-22 |
| EP0772596B1 (en) | 2003-10-01 |
| ES2208685T3 (es) | 2004-06-16 |
| DE69531864D1 (de) | 2003-11-06 |
| WO1996003383A1 (en) | 1996-02-08 |
| JPH10505584A (ja) | 1998-06-02 |
| ATE251158T1 (de) | 2003-10-15 |
| DE69531864T2 (de) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700511A (es) | Inhibidores de spla2 de indolizina. | |
| MY112897A (en) | Ih-indole-3-glyoxylamide spla2 inhibitors | |
| IL130338A0 (en) | Pyrroles as sPLA2 inhibitors | |
| EP0950657A3 (en) | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors | |
| MX9804751A (es) | Naftil acetamidas como inhibidores de la spla2. | |
| EP0310072A3 (en) | Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents | |
| IL130201A0 (en) | Phenyl glyoxamides as spla2 inhibitors | |
| EP1100492A4 (en) | SPLA 2 INHIBITORS? INDOLE TYPE | |
| MX9804750A (es) | Naftil glioxamidas como inhibidores de la spla2. | |
| AU5873400A (en) | spla2 inhibitors | |
| AU1928800A (en) | Substituted tricyclics | |
| WO2002012249A3 (en) | Substituted pyrrole compounds and their use as spla2 inhibitors | |
| AU7053700A (en) | Novel spla2 inhibitors |